Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More

MENU

Sameera Kumar, MD

Department of Radiation Oncology
Dr. Sameera Kumar
4.9
(4.9/5) 65 Patient Satisfaction Ratings

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Assistant Professor

Specialties

Esophageal Cancer;  Lung Cancer;  Lung Metastases;  Mesothelioma;  Thymoma
Education and Training

Educational Background

  • Department of Radiation Oncology, University of Kentucky, Lexington, KY, July 2014-June 2018
    • Resident in Radiation Oncology, 2014-18
    • Chief Resident, 2017-18
  • PhD candidate,  Clinical and Translational Science, University of Kentucky, Lexington, KY,  January 2015- Present
  • MD, West Virginia University School of Medicine, Morgantown, WV, 2013

Certifications

  • American Board of Radiology, Radiation Oncology
Patient Stories

Tiffany Fagnani

Lung Cancer

Tiffany Fagnani

Lung Cancer

I am 40 years old and currently live in Mechanicsburg, Pennsylvania. Although I work as a case manager for an insurance company now, I was previously employed as a full-time nurse. I have always been a busy person with plenty on my plate, so when I started feeling tired and losing weight, I thought it was caused by the stress of my daily routine.

It wasn’t until July 2017 that I couldn’t ignore my symptoms any longer. When I developed a migraine and felt a tremor in my arm and eye, I knew I was about to lose consciousness. I immediately called 911.

Publications

Selected Publications

Kumar, S; Hall, L; Li, X; Downes, L; Shearer, A; Shelton, B; Gerring, S; McGarry, R. “Comparing Dosimetric Parameters and Clinical outcomes among different SBRT modalities.” IJROBP. Submitted.

Kumar, S; Feddock, J; Li, X; Shearer, A; Hall, L; Shelton, B; Arnold, S; McGarry, M. “An Update of a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.” IJROBP. Accepted- In Press. DOI: http://dx.doi.org/10.1016/j.ijrobp.2017.07.036

Kumar, S; Higgins, K; McGarry, R. “Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.” Frontiers of Oncology. Front. Oncol., 04 September 2017.
DOI: https://doi.org/10.3389/fonc.2017.00197

Verma, V; Shostrom, V; Kumar, S; Zhen, W; Hallemeier, C, Braunstein, S; Holland, J; Harkenrider, M; Ishkhanian, A; Neboori, H; Jabbour, S; Attia, A; Lee, P; Alite, F; Walker, J; Stahl, J; Wang, K; Bingham, B; Hadzitheodorou, C; Decker, R; McGarry, R; Simone, C. “Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeter) Non-Small Cell Lung Tumors.” Cancer. September 9, 2016. PubMed

Dong, L; Kudrimoti, M; Irwin, D; Chen, L; Kumar, S; Shang, Y; Huang, C; Johnson, E; Stevens, S; Shelton, B; Yu, G. "Diffuse optical measurements of head and neck tumor hemodynamics for early prediction of chemoradiation therapy outcomes," J. Biomed. Opt. 21(8), 085004 (2016), doi: 10.1117/1.JBO.21.8.085004.

Kumar, SS; Stockham, AL; Chao, ST; Ahluwalia, MS; Suh, JH. “Radiation necrosis: now you see it, now you don’t." Applied Radiology. February 2013.

Additional Publications

Dr. Kumar on PubMed

Ratings

65 PATIENT SATISFACTION REVIEWS

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

OVERALL RATING

4.9 / 5.0

RATINGS BREAKDOWN

  • 5.0
  • 4.9
  • 5.0
  • 5.0
  • 4.9

14 PATIENT COMMENTS

  • 5.0
    June 07, 2021
    Drs. & staff have been excellent all through my treatments.
  • 5.0
    April 23, 2021
    The Nurse that checked me in, the Doctor that came in first to talk to me, and my Doctor that I saw last, (Dr. Sameera Kumar), all made me feel like I was there only patient. What could be better than that?
  • 5.0
    April 21, 2021
    Good experience!
  • 5.0
    March 30, 2021
    good
  • 5.0
    March 04, 2021
    Very happy with care I got.
  • 5.0
    February 10, 2021
    Everyone at Fox Chase is a hero to me.
  • 5.0
    January 21, 2021
    Good experience!
  • 5.0
    January 07, 2021
    Always treated good.
  • No Star Ratings Available December 18, 2020
    Was good and included me in care discussions and treatment.
  • 5.0
    October 01, 2020
    Amazing doctor, amazing hospital.
  • 5.0
    September 02, 2020
    Doctor Sameera Kumar is my best and favorite doctor. Each time I am eager to see her. God bless Kumar and my best wishes of health and happiness to Sameera.
  • 5.0
    July 19, 2020
    very comforting
  • 5.0
    April 20, 2020
    Dr. Kumar has been a great help in keeping me pain-free.
  • 5.0
    March 25, 2020
    Dr. Kumar is a very kind, caring person. She is very warm & friendly. She really knows her cases.
LOAD MORE
Dr. Sameera Kumar

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

4.9
65 Patient Satisfaction Ratings

Assistant Professor

Specialties

Esophageal Cancer;  Lung Cancer;  Lung Metastases;  Mesothelioma;  Thymoma

Education

Educational Background

  • Department of Radiation Oncology, University of Kentucky, Lexington, KY, July 2014-June 2018
    • Resident in Radiation Oncology, 2014-18
    • Chief Resident, 2017-18
  • PhD candidate,  Clinical and Translational Science, University of Kentucky, Lexington, KY,  January 2015- Present
  • MD, West Virginia University School of Medicine, Morgantown, WV, 2013

Certifications

  • American Board of Radiology, Radiation Oncology

Publications

Selected Publications

Kumar, S; Hall, L; Li, X; Downes, L; Shearer, A; Shelton, B; Gerring, S; McGarry, R. “Comparing Dosimetric Parameters and Clinical outcomes among different SBRT modalities.” IJROBP. Submitted.

Kumar, S; Feddock, J; Li, X; Shearer, A; Hall, L; Shelton, B; Arnold, S; McGarry, M. “An Update of a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.” IJROBP. Accepted- In Press. DOI: http://dx.doi.org/10.1016/j.ijrobp.2017.07.036

Kumar, S; Higgins, K; McGarry, R. “Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.” Frontiers of Oncology. Front. Oncol., 04 September 2017.
DOI: https://doi.org/10.3389/fonc.2017.00197

Verma, V; Shostrom, V; Kumar, S; Zhen, W; Hallemeier, C, Braunstein, S; Holland, J; Harkenrider, M; Ishkhanian, A; Neboori, H; Jabbour, S; Attia, A; Lee, P; Alite, F; Walker, J; Stahl, J; Wang, K; Bingham, B; Hadzitheodorou, C; Decker, R; McGarry, R; Simone, C. “Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeter) Non-Small Cell Lung Tumors.” Cancer. September 9, 2016. PubMed

Dong, L; Kudrimoti, M; Irwin, D; Chen, L; Kumar, S; Shang, Y; Huang, C; Johnson, E; Stevens, S; Shelton, B; Yu, G. "Diffuse optical measurements of head and neck tumor hemodynamics for early prediction of chemoradiation therapy outcomes," J. Biomed. Opt. 21(8), 085004 (2016), doi: 10.1117/1.JBO.21.8.085004.

Kumar, SS; Stockham, AL; Chao, ST; Ahluwalia, MS; Suh, JH. “Radiation necrosis: now you see it, now you don’t." Applied Radiology. February 2013.

Additional Publications

Dr. Kumar on PubMed

Related Articles

“We’re dealing with lung cancer and our lung cancer patients may be more at risk for severe disease due to COVID-19. A lot of the management we do puts them at greater risk after that,” said Sameera Kumar, MD, one of the authors on the paper and an assistant professor in the Department of Radiation Oncology.
Fox Chase Researchers Help Identify Best Practices for...
Sameera Kumar, MD
Fox Chase Researchers Study Risks of Recurrence in Lung...
Sameera Kumar Joins the Department of Radiation Oncology at...
Multidisciplinary Cancer Care: What It Means and Why It...

Connect with Fox Chase